Report cover image

Cardiac Remote Patient Monitoring Device Market, by Application (Cardiac Arrhythmias, Ischemic Diseases, and Hypertension), by End Users (Hospitals, Cardiac Clinics, Ambulatory Surgery Centers) and by Region (North America, Latin America, Europe, Asia Pac

Publisher Coherent Market Insights
Published Jan 31, 2022
Length 190 Pages
SKU # CMI16970944

Description

Cardiac Remote Patient Monitoring Device Market, by Application (Cardiac Arrhythmias, Ischemic Diseases, and Hypertension), by End Users (Hospitals, Cardiac Clinics, Ambulatory Surgery Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Remote patient monitoring is a set of practices and technologies authorizing healthcare suppliers to follow real time variations in patient’s health data from space and utilize it in a particular treatment arrangement. Broader telehealth industry and e-health industry are integral component of cardiac remote patient monitoring.

Cardiac monitors are battery-powered devices that record the heart’s electrical activity. These are broadly classified into two categories:

External cardiac monitors – The conventional external heart monitors are designed for short-term use and include holter monitors, event monitors, and loop monitors. They are the most common monitors for diagnosing heart rhythm disorders that occur on a relatively frequent basis, typically attached with wires to the outside of a patient’s body for between 24 hours to 30 days.

Insertable and implantable cardiac monitors – The devices determine the causes of infrequent, unexplained arrhythmias are designed for long-term use (up to three years). The small devices are placed just under the skin to detect and record abnormal heart rhythms during outpatient procedures.

Market Dynamics

The increasing applications of cardiac monitors in continuous monitoring for observation of postoperative patients, patients with severe electrolyte imbalances, prompt identification and initiation of treatment for cardiac arrhythmias, and investments in R&D of heart diseases detection is expected to augment the market growth of the segment over the forecast period. Moreover, increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the Global cardiac remote patient monitoring device market.

Key features of the study:
  • This report provides in-depth analysis of the global cardiac remote patient monitoring device market provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cardiac remote patient monitoring device market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include A & D Medical, BIOTRONIK SE & Co. KG, Boston Scientific, GE Healthcare, Honeywell, Medtronic plc, Nihon Khoden, Philips Healthcare, Spacelabs Healthcare, Abbott Laboratories, St. Jude Medical, VitalConnect Inc., OSYPKA, MeTrax GmbH, and Lepu Medical Technology
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cardiac remote patient monitoring device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac remote patient monitoring device market
Detailed Segmentation:
  • Global Cardiac Remote Patient Monitoring Device Market, By Application:
  • Cardiac Arrhythmia
  • Ischemic Diseases
  • Hypertension
  • Global Cardiac Remote Patient Monitoring Device Market, By End Users:
  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgery Centers
  • Global Cardiac Remote Patient Monitoring Device Market, By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • A & D Medical*
  • Company highlights
  • Product Portfolio
  • Key Highlights
  • Financial performance
  • Strategies
  • BIOTRONIK SE & Co. KG
  • Boston Scientific
  • GE Healthcare
  • Honeywell
  • Medtronic plc
  • Nihon Khoden
  • Philips Healthcare
  • Spacelabs Healthcare
  • Abbott Laboratories
  • St. Jude Medical
  • VitalConnect Inc.
  • OSYPKA
  • MeTrax GmbH
  • Lepu Medical Technology
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

190 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Cancer Type
Market Snippet, By Distribution Channels
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Cancer Analysis
Cancer Epidemiology
Key Challenges
Similar Biologics Approved And Marketed In India
Patient Population
Key Developments
Regulatory Scenario
Adoptive T Cell Therapies
PEST Analysis
Porter’s Five Forces Analysis
4. India Immuno-Oncology Drugs Market– Impact of Coronavirus (Covid-19) Pandemic
Overall Impact of COVID-19 on Healthcare market
COVID-19 Epidemiology
5. India Immuno-Oncology Drugs Market, By Drug Type, 2021 – 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
Immune Checkpoint Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Nivolumab
Atezolimumab
Pembrolizumab
Durvalumab
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Rituximab
Trastazumab
Bevacizumab
Nimotuzumab
Pertuzumab
Ado-Trastuzumab Emtansine
Cancer Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Gardasil
Cervarix
6. India Immuno-Oncology Drugs Market, By Cancer Type, 2021 – 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
Lung cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Blood cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Breast cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Ovarian cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Cervical cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Colorectal cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Stomach cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Head & Neck cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
7. India Immuno-Oncology Drugs Market, By Distribution Channel, 2021 – 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Amgen, Inc.
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
F. Hoffmann-La Roche AG
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Intas Pharmaceuticals Ltd.
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
AstraZeneca plc
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Mylan N.V.
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Dr. Reddy's Laboratories
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Bristol - Myers Squibb
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Merck & Co., Inc.
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
BIOCAD-Biotechnology Company
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Reliance Life Sciences
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Biocon Limited
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
Hetero Drugs Limited
Company highlights
Product Portfolio
Key Highlights
Financial performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 5 market data tables and 20 figures on "India Immuno-Oncology Drugs Market” – India forecast to 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us